DNTH
Dianthus Therapeutics Inc.
85.40$
-3.0%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.2% | -59.5% | +103.6% | -4.6% | -50.5% | +91.2% | +113.2% | +16.6% | -39.0% | -12.3% | -83.4% | +105.2% | -28.3% | +63.0% | +64.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +11.1% | +0.6% | +126.2% | -1.2% | +1.3% | -96.0% | +2,363.3% | -93.0% | -77.4% | +442.1% | +3.9% | +3.7% | +4.5% | -32.8% | +70.5% | -25.6% | +0.0% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -4.0% | -57.7% | +85.9% | +2.3% | -49.5% | +91.2% | +113.2% | +16.6% | -39.0% | -12.3% | -83.4% | +105.2% | -28.3% | +36.3% | +96.6% | – | |
| – | +315.9% | -62.3% | +6.5% | +41.4% | +23.4% | +17.9% | +8.5% | -15.0% | +27.5% | +23.0% | +13.3% | -25.4% | -9.7% | -6.5% | +4.0% | -4.3% | -9.2% | -3.6% | +22.6% | +21.9% | -32.1% | -30.6% | +36.2% | -40.5% | +75.4% | -22.4% | +10.3% | +48.9% | +38.2% | +41.4% | +3.4% | +2.2% | -2.8% | +23.8% | +84.4% | -42.4% | +41.0% | – | |
| – | +28.6% | -5.7% | +45.1% | +32.0% | +25.6% | +21.7% | +4.8% | +4.9% | +1.6% | +3.6% | -3.2% | +22.9% | +1.7% | -10.9% | +3.2% | +2.3% | -7.0% | +15.0% | -5.7% | +3.7% | -11.1% | -65.9% | -7.8% | +13.5% | +7.8% | +250.0% | -46.9% | +21.8% | +6.3% | +8.9% | +4.6% | +7.4% | +20.9% | -7.6% | +21.2% | +25.6% | +8.7% | – | |
| – | +227.0% | -55.4% | +16.5% | +38.4% | +24.0% | +19.1% | +7.4% | -8.8% | +18.3% | +17.1% | +8.8% | -13.8% | -5.8% | -8.2% | +3.7% | -1.9% | -8.4% | +3.4% | +10.7% | +15.4% | -25.4% | -44.2% | +25.4% | -31.0% | +55.2% | +31.6% | -19.5% | +39.6% | +28.6% | +33.3% | +3.6% | +3.3% | +2.3% | +15.8% | +71.6% | -32.8% | +32.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -24.3% | -24.7% | +27.6% | +34.7% | -43.5% | +19.9% | +3.7% | +4.2% | -8.1% | +46.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -141.7% | – | – | |
| – | – | – | +31.4% | +8.2% | +151.7% | +88.2% | +82.1% | +21.2% | +7.5% | +1.5% | -15.4% | +76.1% | -24.3% | -24.7% | +27.6% | +34.7% | -43.5% | +19.9% | +3.7% | +4.2% | -8.1% | -158.1% | – | – | -84.6% | -673.7% | – | -112.6% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -141.7% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -141.5% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.